News

News Banner

Recent News

HRSA Has Released Their Monthly Program Update for February - February 24, 2015

The Health Resources and Services Administration’s Office of Pharmacy Affairs (OPA) has released their monthly program update for February. This month, OPA updates 340B stakeholders on “Program Integrity: Best Practices from Leading Practice Sites.” OPA has shared the best practices that leading practice sites from the 340B Peer-to-Peer Program employ to avoid the three major areas of non-compliance found in audits; eligibility, diversion, and duplicate discounts. Please take the time to read this important .  (View Details)

OPA Director Commander Pedley’s Address to 340B Winter Coalition Meeting - February 16, 2015

During February's 340B Winter Coalition meeting in San Francisco, Office of Pharmacy Affairs Director, Commander Krista Pedley addressed attendees on developments in 340B, advances in the program, and efforts taken to protect program integrity. Commander Pedley also encouraged stakeholders to take advantage of the vast amount of resources available to support 340B compliance including the 340B Peer to Peer program and education and compliance support provided by Apexus. We would like to encourage you to view the video .  (View Details)

2015 State of Apexus - February 10, 2015

During the 2015 340B Coalition Winter Meeting, Apexus President Christopher A. Hatwig gave a presentation on what to expect from 340B, HRSA, the Prime Vendor Program, and Apexus over the next year. The 2015 update touched on a number of topics important to 340B stakeholders. Hatwig explained that Apexus will focus on growing the contract portfolio, maintaining high customer satisfaction, advancing the manufacturer refund program, implementing specialty pharmacy solutions to support access, and expanding educational offerings focused on compliance and program integrity. Please take the time to …  (View Details)

340B Program Demands Compliance; Are You Ready? - January 1, 2015

has published an article on the resources needed to manage the complex requirements of the 340B Program.  In the article, Christopher Hatwig, President of Apexus, explains that the scope of the program extends "way beyond" any one department and therefore, should not be the sole responsibility of the health-system pharmacy.  (View Details)

Apexus Recognized by National Health Care Association for Excellence in Assisting High-Risk Patients to Obtain Necessary Prescription Medicine - November 13, 2014

The Alliance for Integrated Medication Management (AIMM), a nonprofit organization working to expand, extend, and accelerate the work originally initiated through the Patient Safety and Clinical Pharmacy Services Collaborative (PSPC), today awarded its AIMM Builders Award to Apexus, LLC.  (View Details)

Apexus Wins HRSA Contract to Remain Prime Vendor of 340B Program - September 29, 2014

Apexus, LLC, the prime vendor for the 340B Drug Pricing Program, has announced that it has been selected by the Health Resources and Services Administration (HRSA) to continue serving in its role as the prime vendor through September 29, 2019. Apexus, which has held this position for the past 10 years, will continue to work with more than 25,000 safety-net provider locations, drug manufacturers, pharmacy wholesalers, and other stakeholders to negotiate discounts on pharmaceuticals and offer valued services, while supporting compliant operations and helping stakeholders to continue to deliver h …  (View Details)

Genentech Announces Change in Distribution Model for Three Products - September 18, 2014

Genentech announced on September 17 that it will be making a change to the distribution model for Avastin®, Herceptin®, and Rituxan®. Beginning October 1, 2014, Avastin, Herceptin, and Rituxan will be available to hospitals and clinics only through authorized specialty distributors. This change means that all Genentech's infused cancer medicines will now be distributed through specialty distributors.  (View Details)

Apexus Releases OnDemand Learning Opportunity: HIN and 340B - September 17, 2014

What is a health identification number (HIN)? How does it benefit the health industry? How does it enhance operational efficiency? How does it improve program integrity and compliance?  (View Details)

View News Archive